Follow
Craig Thompson
Craig Thompson
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Understanding the Warburg effect: the metabolic requirements of cell proliferation
MG Vander Heiden, LC Cantley, CB Thompson
science 324 (5930), 1029-1033, 2009
164472009
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13275*2021
Apoptosis in the pathogenesis and treatment of disease
CB Thompson
Science 267 (5203), 1456-1462, 1995
98901995
The emerging hallmarks of cancer metabolism
NN Pavlova, CB Thompson
Cell metabolism 23 (1), 27-47, 2016
50852016
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death
MC Wei, WX Zong, EHY Cheng, T Lindsten, V Panoutsakopoulou, ...
Science 292 (5517), 727-730, 2001
49642001
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation
RJ DeBerardinis, JJ Lum, G Hatzivassiliou, CB Thompson
Cell metabolism 7 (1), 11-20, 2008
46852008
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
L Dang, DW White, S Gross, BD Bennett, MA Bittinger, EM Driggers, ...
Nature 462 (7274), 739-744, 2009
46382009
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
LH Boise, M González-García, CE Postema, L Ding, T Lindsten, LA Turka, ...
cell 74 (4), 597-608, 1993
42031993
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf, SW Elmore, AR Shoemaker, RC Armstrong, DJ Augeri, ...
Nature 435 (7042), 677-681, 2005
40772005
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
P Waterhouse, JM Penninger, E Timms, A Wakeham, A Shahinian, ...
Science 270 (5238), 985-988, 1995
36171995
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate
PS Ward, CB Thompson
Cancer cell 21 (3), 297-308, 2012
33682012
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
ME Figueroa, O Abdel-Wahab, C Lu, PS Ward, J Patel, A Shih, Y Li, ...
Cancer cell 18 (6), 553-567, 2010
30732010
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
RJ DeBerardinis, A Mancuso, E Daikhin, I Nissim, M Yudkoff, S Wehrli, ...
Proceedings of the National Academy of Sciences 104 (49), 19345-19350, 2007
28682007
Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
E Yang, J Zha, J Jockel, LH Boise, CB Thompson, SJ Korsmeyer
Cell 80 (2), 285-291, 1995
28611995
CTLA-4 can function as a negative regulator of T cell activation
TL Walunas, DJ Lenschow, CY Bakker, PS Linsley, GJ Freeman, ...
Immunity 1 (5), 405-413, 1994
27821994
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
MA Selak, SM Armour, ED MacKenzie, H Boulahbel, DG Watson, ...
Cancer cell 7 (1), 77-85, 2005
23412005
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate
PS Ward, J Patel, DR Wise, O Abdel-Wahab, BD Bennett, HA Coller, ...
Cancer cell 17 (3), 225-234, 2010
23032010
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry, JM Chemnitz, KA Frauwirth, AR Lanfranco, I Braunstein, ...
Molecular and cellular biology 25 (21), 9543-9553, 2005
22912005
ATP-citrate lyase links cellular metabolism to histone acetylation
KE Wellen, G Hatzivassiliou, UM Sachdeva, TV Bui, JR Cross, ...
Science 324 (5930), 1076-1080, 2009
22052009
IDH mutation impairs histone demethylation and results in a block to cell differentiation
C Lu, PS Ward, GS Kapoor, D Rohle, S Turcan, O Abdel-Wahab, ...
Nature 483 (7390), 474-478, 2012
21682012
The system can't perform the operation now. Try again later.
Articles 1–20